Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics and osteoporosis.

Omar M E Albagha1, Stuart H Ralston

  • 1Rheumatology Section, Molecular Medicine Centre, University of Edinburgh School of Molecular and Clinical Medicine, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom. omar.albagha@ed.ac.uk

Rheumatic Diseases Clinics of North America
|February 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving the clinical diagnosis of familial hypercholesterolemia among patients attending diabetes and cardiology clinics.

American journal of preventive cardiology·2026
Same author

The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis.

The lancet. Healthy longevity·2026
Same author

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

JAMA·2026
Same author

Large vessel vasculitis post granulocyte-colony stimulating factor (G-CSF) use in a patient undergoing neoadjuvant chemotherapy for pancreatic adenocarcinoma.

BMJ case reports·2026
Same author

Quantitative Sensory Testing Reveals Evidence of Altered Pain Processing in Paget's Disease of Bone.

Calcified tissue international·2025
Same author

What is the clinical and cost-effectiveness of surgery with Medial Opening wedge high TIbial Osteotomy compared with Non-surgical treatment (MOTION) in the management of osteoarthritis of the knee in patients younger than 60 years? : a protocol for a multicentre, randomized controlled trial.

Bone & joint open·2025
Same journal

Rheumatology at the Threshold of Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
See all related articles

Genetic factors significantly influence osteoporosis risk, with ongoing research identifying specific genes. Future whole-genome studies promise to uncover more genetic determinants for better diagnosis and treatment.

Area of Science:

  • Genetics
  • Bone Biology
  • Osteoporosis Research

Background:

  • Genetic factors play a crucial role in regulating susceptibility to osteoporosis.
  • Studies reveal that different genes influence bone mineral density (BMD) across various skeletal sites and between sexes.
  • Advances in understanding monogenic bone diseases have identified causative genes, with variations contributing to BMD in the general population.

Purpose of the Study:

  • To review the advances in understanding the genetic regulation of osteoporosis susceptibility.
  • To highlight the progress and limitations of current genetic research methods.
  • To discuss the potential clinical applications of genetic discoveries in osteoporosis.

Main Methods:

  • Review of linkage studies and candidate gene association studies.

Related Experiment Videos

  • Application of meta-analysis to assess the effect size of genetic associations.
  • Anticipation of insights from whole-genome association studies.
  • Main Results:

    • Several chromosomal regions regulating BMD have been identified, but few causative genes discovered via linkage studies.
    • Polymorphic variations in genes causing monogenic bone diseases contribute to normal BMD.
    • Candidate gene studies, including those for vitamin D, have yielded mixed results, often due to underpowered designs.

    Conclusions:

    • Most genetic variants predisposing to osteoporosis are yet to be discovered.
    • Whole-genome association studies are expected to identify genes with modest effect sizes and provide new insights.
    • Identified genetic variants will enhance understanding of osteoporosis pathophysiology, potentially leading to diagnostic tests and novel therapeutic targets.